SWOG clinical trial number
SWOG-7303

Chemotherapy of Disseminated Testicular Carcinoma with Vinblastine (NSC-49842) and Bleomycin (NSC- 125066) or Actinomycin-D (NSC-3053), Bleomycin and Vincristine (NSC-67574)

Closed
Abbreviated Title
Chemotherapy of Disseminated Testicular Carcinoma with Vinblastine (NSC-49842) and Bleomycin (NSC- 125066) or Actinomycin-D (NSC-3053), Bleomycin and Vincristine (NSC-67574)
Activated
02/21/1973
Closed
06/12/1975

Research committees

Genitourinary Cancer

Publication Information Expand/Collapse

1978

Chemotherapy of disseminated germinal tumors of the testis - comparison of vinblastine and bleomycin with vincristine, bleomycin and actinomycin D.

SC Spigel;RL Stephens;CD Haas;SE Jones;D Lehane;TE Moon;CA Coltman Jr Cancer Treat Rep 62(1):129-130

1974

Combination chemotherapy of testicular carcinoma.

SC Spigel;CA Coltman Jr ASCO

1973

Combination chemotherapy of testicular carcinoma.

SC Spigel;CA Coltman Jr ASCO

Other Clinical Trials

SWOG Clinical Trial Number
S2210

S2210, "Targeted Neoadjuvant Treatment for Patients with Localized Prostate Cancer and Germline DNA Repair Deficiency"
Research Committee(s)
Genitourinary Cancer
Activated
08/14/2023
Accrual
2%
Open
Phase
SWOG Clinical Trial Number
S2200

S2200, A Phase II Randomized Trial of Cabozantinib with or Without Atezolizumab in Patients with Advanced Papillary Renal Cell Carcinoma: PAPMET2
Research Committee(s)
Genitourinary Cancer
Activated
09/19/2022
Accrual
8%
Open
Phase
SWOG Clinical Trial Number
CTSU/A031901

Duration of Immune Checkpoint Therapy in Locally Advanced or Metastatic Urothelial Carcinoma: A Randomized Phase 3 Non-Inferiority Trial
Research Committee(s)
Genitourinary Cancer
Activated
05/01/2021
Open
Phase